Home
/
DarioHealth Corp.
/
Financials
/
Quarterly
DarioHealth Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that DarioHealth Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2019
Jun 30, 2019
$1.65M
Aug 13, 2019
Q1
2019
Mar 31, 2019
$2.24M
May 13, 2019
Q3
2018
Sep 30, 2018
$1.88M
Nov 13, 2018
Q2
2019
Jun 30, 2018
$2.06M
Aug 13, 2019
Q1
2019
Mar 31, 2018
$1.76M
May 13, 2019
Q3
2018
Sep 30, 2017
$1.38M
Nov 13, 2018
Q2
2018
Jun 30, 2017
$1.21M
Aug 9, 2018
Q1
2018
Mar 31, 2017
$1.01M
May 15, 2018
Q3
2017
Sep 30, 2016
$728.0K
Mar 19, 2018
Q2
2017
Jun 30, 2016
$669.0K
Mar 19, 2018
Q1
2017
Mar 31, 2016
$568.0K
Mar 19, 2018
Q3
2016
Sep 30, 2015
$273.0K
Nov 10, 2016
Q2
2016
Jun 30, 2015
$175.0K
Aug 11, 2016
Q1
2016
Mar 31, 2015
$67.0K
May 11, 2016
Q3
2015
Sep 30, 2014
$0
Nov 13, 2015
Q2
2015
Jun 30, 2014
$0
Aug 12, 2015
Q1
2015
Mar 31, 2014
$0
May 14, 2015
Q3
2014
Sep 30, 2013
$0
Nov 14, 2014
Q2
2014
Jun 30, 2013
$0
Aug 14, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($10.47M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($12.99M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($9.23M)
May 14, 2025
Q3
2025
Sep 30, 2024
($12.33M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($13.61M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($7.18M)
May 14, 2025
Q3
2024
Sep 30, 2023
($15.73M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($16.59M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($12.83M)
May 15, 2024
Q3
2023
Sep 30, 2022
($15.63M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($18.03M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($15.92M)
May 11, 2023
Q2
2022
Mar 31, 2022
($15.92M)
Aug 15, 2022
Q3
2022
Sep 30, 2021
($22.44M)
Nov 14, 2022
Q3
2021
Jun 30, 2021
($17.77M)
Nov 15, 2021
Q2
2022
Jun 30, 2021
($17.77M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($14.97M)
May 12, 2022
Q2
2022
Mar 31, 2021
($14.97M)
Aug 15, 2022
Q3
2021
Mar 31, 2021
($14.97M)
Nov 15, 2021
Q3
2021
Sep 30, 2020
($6.55M)
Nov 15, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($9.48M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($9.20M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($9.41M)
May 14, 2025
Q3
2025
Sep 30, 2024
($12.03M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($16.19M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($17.86M)
May 14, 2025
Q3
2024
Sep 30, 2023
($15.55M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($14.02M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($12.41M)
May 15, 2024
Q3
2023
Sep 30, 2022
($14.57M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($17.36M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($15.87M)
May 11, 2023
Q3
2022
Sep 30, 2021
($22.50M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($18.00M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($14.33M)
May 12, 2022
Q3
2021
Sep 30, 2020
($6.60M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($4.12M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($10.11M)
May 17, 2021
Q3
2020
Sep 30, 2019
($2.80M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($5.36M)
Aug 12, 2020